BNTX — BioNTech SE stock price, charts and financials

QT46BioNTech SE

BioNTech SE (NASDAQ: BNTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
96.06
-2.60-2.64%
OverviewShort InterestFilings
BNTXQT46BioNTech SE·NASDAQ
96.06-2.64%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 18, 20264Statement of changes in beneficial ownership
Sep 18, 20266-KForeign issuer report
Sep 16, 20264Statement of changes in beneficial ownership
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20266-KForeign issuer report
Sep 11, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Aug 28, 20266-KForeign issuer report
Aug 27, 20266-KForeign issuer report
Aug 20, 20266-KForeign issuer report
Aug 04, 20266-KForeign issuer report
Aug 04, 20266-KForeign issuer report
Aug 03, 20266-KForeign issuer report
Jul 30, 202620-F/A20-F/A
Jul 29, 20266-KForeign issuer report
Jun 26, 20263Initial statement of beneficial ownership
Jun 26, 20263Initial statement of beneficial ownership
Jun 08, 20266-KForeign issuer report
Jun 01, 20266-KForeign issuer report
May 22, 20266-KForeign issuer report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 20266-KForeign issuer report
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20264Statement of changes in beneficial ownership
#1 / 25 of 328
Page
▼
/ 14